We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£102.56
Books on Demand Rift-lines within european regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and ... Framework for Biosimilars When Taking
Price data last checked 50 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£103 today · previous high £103 · all-time low £71
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 41 days · 41 data points (no recent data)
Price Distribution
Price distribution over 41 days • 2 price levels
Price Analysis
Most common price: £71 (25 days, 61.0%)
Price range: £71 - £103
Price levels: 2 different prices over 41 days
Description
Product Specifications
- Brand
- Books on Demand
- Format
- paperback
- ASIN
- 3954891875
- Domain
- Amazon UK
- Release Date
- 26 November 2013
- Listed Since
- 26 November 2013
Barcode
No barcode data available
Similar Products You Might Like
Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development: 34 (AAPS Advances in the Pharmaceutical Sciences Series, 34)
Springer
Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account
GRIN Verlag
Biosimilars: Design and Analysis of Follow-on Biologics: 60 (Chapman & Hall/CRC Biostatistics)
CRC Press
Biosimilars in Cancer
Academic Press
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
Springer
Bispecific Antibodies
Springer
Assessment of Average Bioequivalence in a 2x2 Crossover Design: Exhaustive Statistical Treatment of Drug Levels-Data Generated during a Bioequivalence Study
CREATESPACE
Analytical Characterization of Biotherapeutics
Wiley
Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)
Springer
Managing Biotechnology: From Science to Market in the Digital Age
Wiley
BioPharma Value Chain Management (B&W): A Practical Guide
Infectious Complications in Biologic and Targeted Therapies
Springer
Biosimulation in Biomedical Research, Health Care and Drug Development
Springer
Immunogenicity of Biopharmaceuticals: VIII (Biotechnology: Pharmaceutical Aspects, VIII)
Springer
Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges
Springer
Personalized Medicine: A New Medical and Social Challenge: 2 (Europeanization and Globalization, 2)
Springer
Life Sciences Industry: From Laboratories to Commercialization of Research: 2 (New Paradigms of Living Systems, 2)
Springer
Bioprocessing Technology for Production of Biopharmaceuticals and Bioproducts (Wiley Series in Biotechnology and Bioengineering)
Wiley
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
Springer
Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug Development
Springer
Biopharmaceutical Drug Design and Development
Humana
Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and Heterogeneous Approaches: 30 (Interdisciplinary Applied Mathematics, 30)
Springer
3D Bioprinting and Bio-Regenerative Medicine for Personalized Oncology: Innovations for Personalized Oncology
Elsevier
Biomarker Methods in Drug Discovery and Development (Methods in Pharmacology and Toxicology)
Humana